LG

Luma Group

North America, California, United States, Santa Clara

Description

Luma Group offers electrical appliances and electronic manufacturig.

Investor Profile

Luma Group has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Luma Group frequently co-invest with?

Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Curie.Bio
North America, Massachusetts, United States, Boston
Co-Investments: 1
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 1
AV
South America, Sao Paulo, Brazil, São Paulo
Co-Investments: 1
ArchVentures SA
Europe, Faro, Portugal, Faro
Co-Investments: 1
Mass General Brigham Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Luma Group?

ROME Therapeutics

Cambridge, Massachusetts, United States

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

BiotechnologyHealth CarePharmaceutical
Series BSep 12, 2023
Amount Raised: $72,000,000